EG24224A - Omeprazole sodium salt - Google Patents

Omeprazole sodium salt

Info

Publication number
EG24224A
EG24224A EG74298A EG74298A EG24224A EG 24224 A EG24224 A EG 24224A EG 74298 A EG74298 A EG 74298A EG 74298 A EG74298 A EG 74298A EG 24224 A EG24224 A EG 24224A
Authority
EG
Egypt
Prior art keywords
sodium salt
omeprazole sodium
omeprazole
salt
sodium
Prior art date
Application number
EG74298A
Other languages
English (en)
Inventor
Gustavsson Anders
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG24224A publication Critical patent/EG24224A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG74298A 1997-06-27 1998-06-24 Omeprazole sodium salt EG24224A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B

Publications (1)

Publication Number Publication Date
EG24224A true EG24224A (en) 2008-11-10

Family

ID=20407555

Family Applications (1)

Application Number Title Priority Date Filing Date
EG74298A EG24224A (en) 1997-06-27 1998-06-24 Omeprazole sodium salt

Country Status (34)

Country Link
US (1) US6207188B1 (cs)
EP (2) EP0991641B1 (cs)
JP (1) JP3377218B2 (cs)
KR (1) KR100580987B1 (cs)
CN (1) CN1134432C (cs)
AR (1) AR013350A1 (cs)
AT (1) ATE233756T1 (cs)
AU (1) AU750239B2 (cs)
BR (1) BR9810483A (cs)
CA (1) CA2294614C (cs)
CZ (1) CZ296723B6 (cs)
DE (1) DE69811892T2 (cs)
DK (1) DK0991641T3 (cs)
EE (1) EE03613B1 (cs)
EG (1) EG24224A (cs)
ES (1) ES2191944T3 (cs)
HU (1) HU227976B1 (cs)
ID (1) ID24829A (cs)
IL (2) IL133559A0 (cs)
IS (1) IS1946B (cs)
MY (1) MY127871A (cs)
NO (1) NO318245B1 (cs)
NZ (1) NZ501929A (cs)
PL (1) PL190869B1 (cs)
PT (1) PT991641E (cs)
RU (1) RU2186778C2 (cs)
SA (1) SA98190410B1 (cs)
SE (1) SE510643C2 (cs)
SK (1) SK283958B6 (cs)
TR (1) TR199903270T2 (cs)
TW (1) TW483758B (cs)
UA (1) UA58556C2 (cs)
WO (1) WO1999000380A1 (cs)
ZA (1) ZA985317B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ATE355375T1 (de) 1996-01-04 2006-03-15 Novartis Vaccines & Diagnostic Bakterioferritin aus helicobacter pylori
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
AU4198899A (en) * 1999-05-20 2000-12-12 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
CA2409258A1 (en) * 2000-05-15 2001-11-22 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
US7271182B2 (en) 2000-08-04 2007-09-18 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and use thereof
WO2002015908A1 (fr) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
ATE474559T1 (de) 2001-06-01 2010-08-15 Pozen Inc Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
US20070060556A1 (en) * 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
BRPI0512522A (pt) * 2004-06-24 2008-03-11 Astrazeneca Ab processo para a preparação de sal de sódio de esomeprazol, composto, formulação farmacêutica, e, método de tratamento
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
US8247566B2 (en) * 2005-06-08 2012-08-21 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
MX2011002515A (es) 2008-09-09 2011-04-07 Astrazeneca Ab Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita.
CN101412710B (zh) * 2008-12-16 2010-04-21 海南百那医药发展有限公司 一种奥美拉唑钠化合物及其制法
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
CN102638978A (zh) * 2009-06-25 2012-08-15 波曾公司 用于治疗需要阿司匹林治疗之患者的方法
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102512380B (zh) * 2011-12-20 2013-04-17 海南锦瑞制药股份有限公司 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN102827147B (zh) * 2012-09-13 2013-08-07 山东罗欣药业股份有限公司 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物
CN102871973A (zh) * 2012-10-16 2013-01-16 浙江亚太药业股份有限公司 一种奥美拉唑钠冻干制剂及其制备方法
CN103012371B (zh) * 2013-01-05 2014-02-12 宁辉 奥美拉唑钠结晶化合物、其制备方法及其药物组合物
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物
CN104788426B (zh) * 2015-04-02 2015-12-30 天津大学 一种奥美拉唑钠半水合物及其制备方法
EP4598528A1 (en) 2022-10-04 2025-08-13 Arsenil Zabirnyk Inhibition of aortic valve calcification
CN116041325B (zh) * 2022-12-09 2025-03-07 山东北大高科华泰制药有限公司 稳定化质子泵抑制剂的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2719916C2 (de) * 1977-05-04 1987-03-19 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
ES2023778A6 (es) * 1990-12-12 1992-02-01 Genesis Para La Investigacion Procedimiento para preparar sales alcalinas del omeprazol
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
JP3350054B2 (ja) 1994-07-08 2002-11-25 アストラゼネカ・アクチエボラーグ 複数単位の錠剤化された剤形▲ｉ▼
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
EP0968205A1 (en) * 1997-03-07 2000-01-05 A/S GEA Farmaceutisk Fabrik Process for the preparation of 2- (2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose
AU5982198A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
BR9810483A (pt) 2000-09-12
EE9900593A (et) 2000-08-15
US6207188B1 (en) 2001-03-27
HK1026699A1 (en) 2000-12-22
SE510643C2 (sv) 1999-06-14
CA2294614C (en) 2002-01-08
SE9702483L (sv) 1998-12-28
MY127871A (en) 2006-12-29
RU2186778C2 (ru) 2002-08-10
NO996440L (no) 2000-02-08
CN1261362A (zh) 2000-07-26
ID24829A (id) 2000-08-24
HU227976B1 (en) 2012-07-30
TW483758B (en) 2002-04-21
AR013350A1 (es) 2000-12-27
NZ501929A (en) 2001-06-29
IS1946B (is) 2004-10-13
CZ296723B6 (cs) 2006-05-17
SA98190410B1 (ar) 2006-06-10
DE69811892D1 (de) 2003-04-10
JP3377218B2 (ja) 2003-02-17
HUP0003017A3 (en) 2002-01-28
EP1186602A2 (en) 2002-03-13
IL133559A (en) 2006-04-10
HUP0003017A2 (hu) 2001-06-28
DE69811892T2 (de) 2004-03-04
SE9702483D0 (sv) 1997-06-27
JP2001508805A (ja) 2001-07-03
WO1999000380A1 (en) 1999-01-07
KR20010014165A (ko) 2001-02-26
EP0991641B1 (en) 2003-03-05
EP1186602A3 (en) 2002-03-27
DK0991641T3 (da) 2003-05-19
EE03613B1 (et) 2002-02-15
SK283958B6 (sk) 2004-06-08
AU8135398A (en) 1999-01-19
AU750239B2 (en) 2002-07-11
NO318245B1 (no) 2005-02-21
IL133559A0 (en) 2001-04-30
TR199903270T2 (xx) 2000-07-21
UA58556C2 (uk) 2003-08-15
NO996440D0 (no) 1999-12-23
KR100580987B1 (ko) 2006-05-17
SK172999A3 (en) 2000-07-11
PL337735A1 (en) 2000-08-28
ZA985317B (en) 1999-01-11
ATE233756T1 (de) 2003-03-15
CA2294614A1 (en) 1999-01-07
PT991641E (pt) 2003-06-30
CZ469999A3 (cs) 2000-08-16
EP0991641A1 (en) 2000-04-12
IS5314A (is) 1999-12-21
ES2191944T3 (es) 2003-09-16
PL190869B1 (pl) 2006-02-28
CN1134432C (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
EG24224A (en) Omeprazole sodium salt
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
GB2336364B (en) Paroxetine salt
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
PL337181A1 (en) Novel salt
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9721021D0 (en) Phosphonium salt composition
GB9715821D0 (en) Amidino-camptothecin derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
EP1091916A4 (en) CATAPLASM FOR SALT REMOVAL
GB9809350D0 (en) Novel salt
ZA983116B (en) Arylsecocholadiene derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
SI0991641T1 (en) Crystalline form of omeprazole sodium salt
CA80083S (en) Hanger
CA81531S (en) Hanger
PL106988U1 (en) Salt light